Find and Pitch Jounalists, Get Your Story Covered

Tags: statins statin lipid statin therapy kidney disease

	Profile	Recent Articles on Subject
1	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 5 days ago STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more - 6 days ago STAT+: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried - 3 months ago STAT+: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH - 7 months ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - 10 months ago STAT+: With new trial data, a blockbuster therapy from Sanofi, Regeneron could find an even bigger market - 10 months ago STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial - 12 months ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 6 days ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 2 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 2 months ago STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more - 6 months ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - 9 months ago STAT+: Pharmalittle: Wegovy cuts heart attack risk in milestone trial; AstraZeneca prioritizes U.S. for RSV drug amid surge - 10 months ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - 11 months ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - 11 months ago
3	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome - 8 days ago
4	Randy Dotinga MedPage Today Indie scribbler, advocate. Board member, @ahcj. San Diego WritingAdvocacy	Statin Use Linked to Higher Risk of Glaucoma - about 2 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Tirzepatide Shows Improvements in MASH Without Worsening Fibrosis - 3 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 6 months ago Statins Could Potentially Slow Deterioration of Cognitive Function for Those With Alzheimer Disease - 9 months ago Study: Statin Use Associated With Reduced Breast Cancer Mortality - 9 months ago
6	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: FDA rejects Rocket Pharmaceuticals’ gene therapy for ultra-rare condition, another setback for field - 3 months ago
7	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease - 3 months ago STAT+: After decades in use, heart stents finally beat placebo. It took a bold researcher - 10 months ago
8	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	Third-Generation PCSK9 Inhibitor Cuts Cholesterol With Single, Small, Monthly Shot - 5 months ago Self-Selection for Statin Appears Safe, Effective - 5 months ago Antisense Drug Slashes High Triglycerides - 5 months ago
9	Ed Susman MedPage Today Freelance Medical journalist. Owns medical site. West Palm Beach, Florida medical journalismwritinghealthcare	Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial - 5 months ago
10	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients - 5 months ago ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MI - 6 months ago First DCB Approved; DAPT Bleeds With Low LDL-C; Pre-CABG Cardiac Rehab - 7 months ago Statins and CKD; Farxiga's Limited Symptom Improvement; Stop Wasted TNKase - 9 months ago Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops - 10 months ago Statins Reach More Patients With Pharmacist's Orders - 10 months ago Novel PCSK9 Inhibitor Recaticimab Lowers Lipids With Less Frequent Shots - 10 months ago Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering - 10 months ago Angioplasty Redeemed for Stable Angina in Sham-Controlled ORBITA-2 - 10 months ago Highly Potent Statin Stands Out for Diabetes, Cataract Risks - 11 months ago FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage - about 1 year ago

Journalists covering statin therapy